Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Mutagenesis Induced by Sub-Lethal Doses of Ciprofloxacin: Genotypic and Phenotypic Differences Between the Pseudomonas aeruginosa Strain PA14 and Clinical Isolates

Texto completo
Autor(es):
Migliorini, Leticia Busato [1] ; Bruggemann, Holger [2] ; de Sales, Romario Oliveira [1] ; Mariko Koga, Paula Celia [3] ; de Souza, Andrea Vieira [1] ; Valle Martino, Marines Dalla [3] ; Galhardo, Rodrigo S. [4] ; Severino, Patricia [1]
Número total de Autores: 8
Afiliação do(s) autor(es):
[1] Albert Einstein Res & Educ Inst, Hosp Israelita Albert Einstein, Sao Paulo - Brazil
[2] Aarhus Univ, Dept Biomed, Aarhus - Denmark
[3] Hosp Israelita Albert Einstein, Lab Clin, Sao Paulo - Brazil
[4] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo - Brazil
Número total de Afiliações: 4
Tipo de documento: Artigo Científico
Fonte: FRONTIERS IN MICROBIOLOGY; v. 10, JUL 10 2019.
Citações Web of Science: 0
Resumo

Bacterial resistance is a severe threat to global public health. Exposure to sub-lethal concentrations has been considered a major driver of mutagenesis leading to antibiotic resistance in clinical settings. Ciprofloxacin is broadly used to treat infections caused by Pseudomonas aeruginosa, whereas increased mutagenesis induced by sub-lethal concentrations of ciprofloxacin has been reported for the reference strain, PAO1, in vitro. In this study we report increased mutagenesis induced by sub-lethal concentrations of ciprofloxacin for another reference strain, PA14-UCBPP, and lower mutagenesis for clinical isolates when compared to the reference strain. This unexpected result may be associated with missense mutations in imuB and recX, involved in adaptive responses, and the presence of Pyocin S2, which were found in all clinical isolates but not in the reference strain genome. The genetic differences between clinical isolates of P. aeruginosa and the reference PA14-UCBPP, often used to study P. aeruginosa phenotypes in vitro, may be involved in reduced mutagenesis under sub-lethal concentrations of CIP, a scenario that should be further explored for the understanding of bacterial fitness in hospital environments. Moreover, we highlight the presence of a complete umuDC operon in a P. aeruginosa clinical isolate. Even though the presence of umuDC did not contribute to a significant increase in mutagenesis, it highlights the dynamic exchange of genetic material between bacterial species in the hospital environment. (AU)

Processo FAPESP: 15/18886-0 - Papel dos Mecanismos de Reparo de DNA na resposta de Pseudomonas aeruginosa aos antimicrobianos ciprofloxacina e Ceftazidima
Beneficiário:Letícia Busato Migliorini
Linha de fomento: Bolsas no Brasil - Mestrado